How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

32,045 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

2. General Principles e30 2.1. Definitions: Terms and Classification e30 2.2. Epidemiology and Demographics e31 2.3. Initial Evaluation of Patients with Syncope: Recommendations e31 2.3.1. History and Physical Examination: Recommendation e31 2.3.2. Electrocardiography: Recommendation e31 2.3.3. Risk Assessment: Recommendations e32 2.3.4. Disposition After Initial Evaluation: Recommendations e32 3. Additional Evaluation and Diagnosis e33 3.1. Blood Testing: Recommendations e33 3.2. Cardiovascular (...) vision” or “graying out”; and variable degrees of altered consciousness without complete loss of consciousness. Presyncope could progress to syncope, or it could abort without syncope. Unexplained syncope (syncope of undetermined etiology) Syncope for which a cause is undetermined after an initial evaluation that is deemed appropriate by the experienced healthcare provider. The initial evaluation includes but is not limited to a thorough history, physical examination, and ECG. Orthostatic intolerance

2017 American Heart Association

102. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

and Classification e67 2.2. Epidemiology and Demographics e67 2.3. Initial Evaluation of Patients with Syncope: Recommendations e67 2.3.1. History and Physical Examination: Recommendation e68 2.3.2. Electrocardiography: Recommendation e68 2.3.3. Risk Assessment: Recommendations e68 2.3.4. Disposition After Initial Evaluation: Recommendations e69 3. Additional Evaluation and Diagnosis e70 3.1. Blood Testing: Recommendations e70 3.2. Cardiovascular Testing: Recommendations e71 3.2.1. Cardiac Imaging (...) degrees of altered consciousness without complete loss of consciousness. Presyncope could progress to syncope, or it could abort without syncope. Unexplained syncope (syncope of undetermined etiology) Syncope for which a cause is undetermined after an initial evaluation that is deemed appropriate by the experienced healthcare provider. The initial evaluation includes but is not limited to a thorough history, physical examination, and ECG. Orthostatic intolerance A syndrome consisting

2017 American Heart Association

103. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

this page Access provided by Volume 70, Issue 6, Pages 737–751 KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) x Tamara Isakova Affiliations Division of Nephrology and Hypertension, Department of Medicine and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (...) KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) - American Journal of Kidney Diseases Email/Username: Password: Remember me Search Terms Search within Search Share

2017 National Kidney Foundation

104. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Hypertension Search Hello Guest! Login to your account Email Password (...) and Obesity e28 5.2.2. Sodium Intake e29 5.2.3. Potassium e29 5.2.4. Physical Fitness e29 5.2.5. Alcohol e29 5.3. Childhood Risk Factors and BP Tracking e31 5.4. Secondary Forms of Hypertension e32 5.4.1. Drugs and Other Substances With Potential to Impair BP Control e32 5.4.2. Primary Aldosteronism e32 5.4.3. Renal Artery Stenosis e34 5.4.4. Obstructive Sleep Apnea e34 6. Nonpharmacological Interventions e35 6.1. Strategies e35 6.2. Nonpharmacological Interventions e35 7. Patient Evaluation e38 7.1

2017 American Heart Association

105. Peer Review Practices for Evaluating Biomedical Research Grants: A Scientific Statement From the American Heart Association

their peer review practices. Recommendations for Best Practices Our review of peer review found several themes. Peer review procedures and practices have a deep history and robust procedures. A remarkable amount of thought and energy go into peer review. Robust peer review is considered the state-of-the-art standard when it comes to the evaluation of scientific proposals for funding. However, it is not a perfect process, and legitimate concerns about specific areas of peer review exist. The published (...) Peer Review Practices for Evaluating Biomedical Research Grants: A Scientific Statement From the American Heart Association Peer Review Practices for Evaluating Biomedical Research Grants: A Scientific Statement From the American Heart Association | Circulation Research Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 February 2019 February 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you

2017 American Heart Association

106. Evaluation of Abnormal Liver Chemistries

of elevation of ALT and or AST in the clinical setting helps guide the evaluation. The evaluation of hepatocellular injury includes testing for viral hepatitis A, B, and C, assessment for nonalcoholic fatty liver disease and alcoholic liver disease, screening for hereditary hemochromatosis, autoimmune hepatitis, Wilson’s disease, and alpha-1 antitrypsin de? ciency. In addition, a history of prescribed and over-the-counter medicines should be sought. For the evaluation of an alkaline phosphatase elevation (...) the likelihood of hepatomegaly being present but in and of itself does not imply an enlarged liver is present ( 76,77 ). A fi rm Before initiation of evaluation of abnormal liver chemistries, one should repeat the lab panel and/or perform a clarifying test (e.g., GGT if serum alkaline phosphate is elevated) to confi rm that the liver chemistry is actually abnormal. Th e initial history should assess risk factors for liver diseases including viral hepatitis, meta- bolic liver disease, exposures to toxins

2017 American College of Gastroenterology

107. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | Hypertension Search Hello Guest (...) Treatment of Hypertension 1286 8.1.3. Follow-Up After Initial BP Evaluation 1287 8.1.4. General Principles of Drug Therapy 1288 8.1.5. BP Goal for Patients With Hypertension 1290 8.1.6. Choice of Initial Medication 1290 8.2. Follow-Up of BP During Antihypertensive Drug Therapy 1290 8.2.1. Follow-Up After Initiating Antihypertensive Drug Therapy 1290 8.2.2. Monitoring Strategies to Improve Control of BP in Patients on Drug Therapy for High BP 1291 9. Hypertension in Patients With Comorbidities 1291 9.1

2017 American Heart Association

108. SPRINT: Evaluation of Intensive <120mmHg vs. Standard <140mmHg Blood Pressure Targets

SPRINT: Evaluation of Intensive <120mmHg vs. Standard <140mmHg Blood Pressure Targets RXFILES TRIAL SUMMARY SPRINT www.RxFiles.ca DEC 2015 Page 1 of 5 SPRINT 1 : Evaluation of Intensive 15% but not a high degree of comorbidity ?Those who achieve such BP control, without requiring a high number of antihypertensives and do not have difficulty tolerating adverse effects of therapy Who may not be suitable? ?Those with type-2 diabetes, history of stroke, proteinuric kidney disease or heart failure (...) SPRINT www.RxFiles.ca DEC 2015 Page 4 of 5 UNCERTAINITIES: ? To what extent are the results generalizable to patients who did not meet the inclusion/exclusion criteria? - Of US adults 13 : ?Only about 17% of hypertension patients meet the SPRINT eligibility criteria ?Only about 8% overall meet the SPRINT eligibility criteria ? Is lower better in all patients? The J-curve concept in a high CV risk population (i.e. ?BP is only bene?cial to a certain target and then becomes harmful) may be significant

2016 RxFiles

109. Patient-Level Prediction of Cardio-Cerebrovascular Events in Hypertension Using Nationwide Claims Data. (PubMed)

' medical history across all health care providers in Korea (N=51,920). To ensure the generalizability of our models, we conducted an external validation using another national sample cohort dataset, comprising one million different patients, published by the National Health Insurance Service. From each dataset, we obtained the data of 74,535 and 59,738 patients with essential hypertension and developed machine learning models for predicting cardiovascular and cerebrovascular events. Six machine (...) learning models were developed and compared for evaluating performances based on validation metrics.Machine learning algorithms enabled us to detect high-risk patients based on their medical history. The long short-term memory-based algorithm outperformed in the within test (F1-score=.772, external test F1-score=.613), and the random forest-based algorithm of risk prediction showed better performance over other machine learning algorithms concerning generalization (within test F1-score=.757, external

Full Text available with Trip Pro

2019 Journal of medical Internet research

110. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. (PubMed)

targets for the treatment of hypertension in adults aged 60 years or older.This guideline is based on a systematic review of published randomized, controlled trials for primary outcomes and observational studies for harms only (identified through EMBASE, the Cochrane Database of Systematic Reviews, MEDLINE, and ClinicalTrials.gov), from database inception through January 2015. The MEDLINE search was updated through September 2016. Evaluated outcomes included all-cause mortality, morbidity (...) Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood pressure

Full Text available with Trip Pro

2017 Annals of Internal Medicine

111. MKSAP: 56-year-old woman pulmonary hypertension

MKSAP: 56-year-old woman pulmonary hypertension Patent ductus arteriosus with Eisenmenger syndrome MKSAP: 56-year-old woman pulmonary hypertension | | January 19, 2019 2 Shares Test your medicine knowledge with the , in partnership with the . A 56-year-old woman is evaluated during an appointment to establish care. She has a developmental delay, and she is known to have pulmonary hypertension due to a congenital cardiac condition. There is no history of cardiac surgery. She is on low-dose (...) hands appear normal. The remainder of the physical examination is unremarkable. Which of the following is the most likely cause of this patient’s pulmonary hypertension? A. Atrial septal defect B. Patent ductus arteriosus C. Tetralogy of Fallot D. Ventricular septal defect MKSAP Answer and Critique The correct answer is B. Patent ductus arteriosus. The patient has a patent ductus arteriosus (PDA) with secondary pulmonary hypertension (Eisenmenger syndrome). Clinical features of an Eisenmenger PDA

2019 KevinMD blog

112. Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. (PubMed)

Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. Previous evidence suggest that high low-density lipoprotein cholesterol (LDL-C) and serum uric acid (SUA) levels are risk factors for endothelial dysfunction and vascular ageing. The aim of our study was to evaluate the short-term interaction between SUA, LDL-C and incident hypertension in a sample of overall healthy individuals.In January 2018, we (...) selected from the general database of the Brisighella Heart Study four groups of age and sex-matched nonhypertensive individuals with different levels of LDL-C and SUA level and examined during the 2008 population survey. Incident hypertension has been defined as the increase of SBP values over 140 mmHg and/or of DBP over 90 mmHg and or the beginning of an antihypertensive treatment.In a model adjusted for age, sex, baseline blood pressure, family history of hypertension, smoking status, BMI

2019 Journal of Hypertension

113. Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline. (PubMed)

Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline. To evaluate the prevalence of apparent treatment-resistant hypertension (aTR-hypertension) in US adults with treated hypertension by using the nationally representative National Health and Nutrition Examination Survey (NHANES).Nonpregnant US adults older than 20 years with a self-reported history of treated hypertension who had blood pressure measured in NHANES (...) cycles 2007 to 2014 were included in this study. Study participants were stratified into 4 groups according to average blood pressure and antihypertensive medication use: well-controlled hypertension, undertreated hypertension, aTR-hypertension by the 2017 guideline, and aTR-hypertension by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guideline. National Health and Nutrition Examination Survey sample weights were

2019 Mayo Clinic Proceedings

114. Natural History Study of CEP290-Related Retinal Degeneration

the natural history of CEP290-related retinal degeneration caused by a compound heterozygous or homozygous intron 26 c.2991+1655A>G mutation and to better understand the best assessments for evaluation of patients with this condition in a future interventional trial. Patients meeting the entry criteria will be enrolled in the study. Visits will occur at Screening, Baseline, and Months 3, 6, and 12, for a total duration of 1 year. Study Design Go to Layout table for study information Study Type (...) of the study (eg, uncontrolled systemic hypertension, autoimmune disease, advanced coronary artery disease, or cerebral vascular disease, other unstable or progressive cardiovascular, pulmonary, Parkinson's, liver or renal disease, cancer, or dementia). Has history or current evidence of ocular disease in either eye that, in the opinion of the Investigator, may confound assessment of this inherited retinal disease or the assessments utilized herein (eg, glaucoma, age-related macular degeneration, diabetic

2017 Clinical Trials

115. Put the Family Back in Family Health History: A Multiple-Informant Approach. (PubMed)

Put the Family Back in Family Health History: A Multiple-Informant Approach. An accurate family health history is essential for individual risk assessment. This study uses a multiple-informant approach to examine whether family members have consistent perceptions of shared familial risk for four common chronic conditions (heart disease, Type 2 diabetes, high cholesterol, and hypertension) and whether accounting for inconsistency in family health history reports leads to more accurate risk (...) assessment.In 2012-2013, individual and family health histories were collected from 127 adult informants of 45 families in the Greater Cincinnati Area. Pedigrees were linked within each family to assess inter-informant (in)consistency regarding common biological family member's health history. An adjusted risk assessment based on pooled pedigrees of multiple informants was evaluated to determine whether it could more accurately identify individuals affected by common chronic conditions, using self-reported

Full Text available with Trip Pro

2017 American journal of preventive medicine

116. The natural history and surgical outcome of patients with scimitar syndrome: a multi-centre European study. (PubMed)

The natural history and surgical outcome of patients with scimitar syndrome: a multi-centre European study. Treatment decisions in patients with scimitar syndrome (SS) are often challenging, especially in patients with isolated SS who are often asymptomatic and who might be diagnosed accidentally. We queried a large multi-institutional registry of SS patients to evaluate the natural history of this condition and to determine the efficacy of surgical treatment in terms of survival and clinical (...) hypertension. Surgical treatment of SS is beneficial in reducing symptoms, however, given the significant risk of post-operative scimitar drainage stenosis/occlusion, it should be tailored to a comprehensive haemodynamic evaluation and to the patient's age.

2017 European Heart Journal

117. Optic Disc Drusen and Family History of Glaucoma-Results of a Patient-directed Survey. (PubMed)

Optic Disc Drusen and Family History of Glaucoma-Results of a Patient-directed Survey. Prospective evaluation of family history (FH) of glaucoma and FH of optic disc drusen (ODD) in patients with sonographically confirmed ODD.A total of 87 patients with ODD interviewed all their first-degree and second-degree relatives using a detailed questionnaire on whether an ophthalmologist had diagnosed or excluded glaucoma or ocular hypertension (OH). Using a second questionnaire, 62 of these patients (...) also provided information about ODD in their FH. Control groups for FH of glaucoma consisted of 2170 patients with glaucoma or OH evaluated with the same methods and identical questions for FH of glaucoma in a previous study, and of 176 healthy individuals without glaucoma or ODD who were interviewed on family history of glaucoma.Glaucoma in FH was significantly more frequent in patients with ODD with an incidence of 20.7% compared with healthy controls with an incidence of 2.8%, and half

2017 Journal of Glaucoma

118. Natural History and Clinical Predictors of Atrial Tachycardia in Adults With Congenital Heart Disease. (PubMed)

Natural History and Clinical Predictors of Atrial Tachycardia in Adults With Congenital Heart Disease. Atrial tachycardias (ATs) are a significant source of morbidity in adults with congenital heart disease (CHD). This study evaluates the incidence and clinical predictors of AT in a cohort of patients with CHD.We included 3311 adults (median age at entry 22.6 years, 50.6% males) with CHD (49% simple, 39% moderate, and 12% complex) prospectively followed up in a tertiary center for 37 607 person (...) CHD. Independent risk factors for developing AT were univentricular physiology, previous intracardiac repair, systemic right ventricle, pulmonary hypertension, pulmonary regurgitation, pulmonary atrioventricular valve regurgitation, pulmonary and systemic ventricular dysfunction. At the age of 40 years, AT-free survival in patients with 0, 1, 2, and ≥3 risk factors was 100%, 94%, 76%, and 50%, respectively. These findings were confirmed in the validation cohort.Natural history of AT differed among

Full Text available with Trip Pro

2017 Circulation. Arrhythmia and electrophysiology

119. Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. (PubMed)

Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom. Primary sclerosing cholangitis (PSC) is a rare obliterative fibrotic condition of the bile ducts. We assessed PSC epidemiology and natural history within the UK Clinical Practice Research Datalink (CPRD).Incidence and natural history of PSC were evaluated in a retrospective cohort study using linkage of CPRD, Hospital Episode Statistics, and Office for National Statistics data. Data from age, sex (...) , and general practice-matched population controls provided a context for the incident PSC patients. Liver disease other than PSC was defined as autoimmune hepatitis, hepatitis, hepatomegaly, liver failure, cirrhosis, portal hypertension, cholangiocarcinoma, or hepatobiliary cancer.The age-standardized incidence of PSC was 0.68 (95% confidence interval [CI] 0.45-0.99) per 100,000 person-years and the age-standardized prevalence was 5.58 (95% CI 4.82-7.35) per 100,000 during 1998 to 2014. In all, 250

Full Text available with Trip Pro

2017 Medicine

120. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. (PubMed)

Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults. Background: There is a potential role of choline in cardiovascular and cerebrovascular disease through its involvement in lipid and one-carbon metabolism.Objective: We evaluated the associations of plasma choline and choline-related compounds with cardiometabolic risk factors, history of cardiovascular disease (...) and small- and large-vessel infarcts). Multiple linear and logistic regression models were used to examine relations of plasma measures with cardiometabolic risk factors, history of cardiovascular disease, and radiologic evidence of cerebrovascular pathology.Results: Higher concentrations of plasma choline were associated with an unfavorable cardiometabolic risk-factor profile [lower high-density lipoprotein (HDL) cholesterol, higher total homocysteine, and higher body mass index (BMI)] and greater odds

Full Text available with Trip Pro

2017 American Journal of Clinical Nutrition

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>